Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1989 May;86(9):3428-32.
doi: 10.1073/pnas.86.9.3428.

Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test

G Cirino  1 , S H Peers, R J Flower, J L Browning, R B Pepinsky
Affiliations
Comparative Study

Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test

G Cirino et al. Proc Natl Acad Sci U S A. 1989 May.

Abstract

Human recombinant lipocortin 1 has been tested for anti-inflammatory activity in a conventional model of acute inflammation. Microgram amounts of the protein, locally administered, inhibited edema of the rat paw when induced by subplantar injections of carrageenin: the ED50 was 10-20 micrograms per paw, and inhibition (maximum of 60-70%) was not dependent upon an intact adrenal cortex. Doses of lipocortin that produced approximately 50% inhibition in the carrageenin test were inactive against edema elicited by bradykinin, serotonin, platelet-activating factor-acether, or dextran, whereas edema caused by Naja mocambique venom phospholipase A2 was strongly inhibited by lipocortin. The protein inhibited edema when rats were pretreated with agents that depleted mast-cell amines, kininogen, or polymorphonuclear leukocytes prior to initiation of the carrageenin edema but had no inhibitory action when rats were pretreated with the dual cyclooxygenase/lipoxygenase inhibitor BW 755C. These results demonstrate that human recombinant lipocortin has potent local anti-inflammatory activity, probably through selectively interfering with eicosanoid generation. Lipocortin is relatively ineffective against edema caused by mast-cell degranulation or kinins, except when degranulation is caused by phospholipase A2.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Pathol. 1971 May;104(1):15-29 - PubMed
    1. Eur J Pharmacol. 1988 May 20;150(1-2):131-5 - PubMed
    1. Biochem Pharmacol. 1977 Apr 15;26(8):693-8 - PubMed
    1. J Pharm Pharmacol. 1977 Nov;29(11):702-4 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 May;78(5):3190-4 - PubMed

Publication types

MeSH terms